Pediatrix Medical Group Inc
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
The following Consolidated Financial Statements and Financial Statement Schedule of Pediatrix Medical Group, Inc. and its subsidiaries, together with the report thereon of PricewaterhouseCoopers LLP (PCAOB ID 238), are included in this Form 10-K on the pages set forth below:
INDEX TO FINANCIAL STATEMENTS
AND FINANCIAL STATEMENT SCHEDULE
| Page | |
|---|---|
| Consolidated Financial Statements | |
| Report of Independent Registered Public Accounting Firm | 70 |
| Consolidated Balance Sheets at December 31, 2024 and 2023 | 73 |
| Consolidated Statements of Income and Comprehensive Income for the Years Ended December 31, 2024, 2023 and 2022 | 74 |
| Consolidated Statements of Equity for the Years Ended December 31, 2024, 2023 and 2022 | 75 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022 | 76 |
| Notes to Consolidated Financial Statements | 77 |
| Financial Statement Schedule | |
| Schedule II – Valuation and Qualifying Accounts for the Years Ended December 31, 2024, 2023 and 2022 | 99 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.